Intended Audience:
This webcast is designed for all physician specialists who may manage patients with MRSA infection, including: emergency medicine specialists, medical directors of emergency departments, hospitalists, infectious disease specialists, pulmonary medicine specialists, critical care physicians, general, vascular, and orthopedic surgery specialists, hospital-based dermatologists, hospital infectious control experts, and hospital-based pharmacists with infectious disease specialty interest
Registration:
Enrollment for this course is complimentary, and clinicians are invited to participate in this CME-certified webcast and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Grantor Support:
Supported by an independent educational grant from Pfizer, Inc.
Accreditation Statement for Jointly-Sponsored Programs:
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of The University of Massachusetts Medical School
and CMEducation Resources, LLC. The University of Massachusetts Medical School
is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Massachusetts Medical School designates this educational activity
for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure:
It is the policy of the University of Massachusetts Medical School to ensure fair
balance, independence, objectivity and scientific rigor in all activities. All
faculty participating in CME activities sponsored by the University of Massachusetts
Medical School are required to present evidence-based data, identify and reference
off-label product use and disclose all relevant financial relationships with those
supporting the activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials.
Faculty Disclosures:
Dr. Gums discloses that he receives research grants from Pfizer, Roche, Merck, and Wyeth-Ayerst. He serves as a consultant for sanofi-aventis, Roche, and Wyeth-Ayerst, and he receives honoraria from Wyeth-Ayerst, Roche, and sanofi-aventis.
Dr. Stevens is a Clinical Investigator for Pfizer, Wyeth, Amgen and Roche; and a Research Consultant for Pfizer, Wyeth, and Cubist.
Dr. Volturo has no conflicts to disclose.
Educational Objectives:
-
Ensure appropriate patient evaluation, diagnosis, and antibiotic therapy in community- and hospital-based MRSA infections.
-
Develop strategies for reducing hospital length of stay, indications for outpatient oral vs. inpatient intravenous therapy
-
Learn approaches to step down therapy.
-
Emphasize improving patient outcomes, using evidence-based trials and expert analysis for guidance on multiple clinical decisions points related to management of MRSA-CAP patients.
Distinguished Program Faculty and Panel Members
Gregory A.
Volturo
, MD, FACEP
(Program Chairman)
Vice Chairman, Department of Emergency Medicine
Associate Professor of Emergency Medicine and Medicine
University of Massachusetts Medical School
Worcester, MA
John G.
Gums
, Pharm. D.
Professor
Pharmacy and Medicine
Director of Clinical Research in Family Medicine
Departments of Pharmacy Practice and Family Medicine
University of Florida
Gainesville, FL
Dennis L.
Stevens
, MD, Pharm. D.
Professor of Medicine
Chief, Infectious Disease Section
Veterans Affairs Medical Center
University of Washington
Seattle, WA
Copyright (c) 2006 All rights reserved including
